LOGC

LogicBio’s inventory skyrockets after buyout bid for a 667% premium

[ad_1] Shares of LogicBio Therapeutics Inc. LOGC, +641.32% skyrocketed greater than seven-fold (up 643%) in morning buying and selling, to…

2 years ago